IN8BIO, INC.

Nasdaq:INAB

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-K/A	FY 2024	12/31/24	5/7/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K	FY 2024	12/31/24	3/13/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/7/25	Q2 FY2025	→
3/13/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

52 shown

Filed	Type	Description
2/27/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/9/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/19/25	Agreement	Entry into a Material Definitive Agreement	→
11/24/25	Other	Other Events	→
10/27/25	Other	Other Events	→
6/30/25	Other	Other Events	→
↓

Prospectuses & Registrations

34 shown

Filed	Form	Description
1/30/26	424B3	424B3	→
1/20/26	S-3	S-3	→
11/7/25	S-3	S-3	→
3/17/25	ARS	ARS	→
3/13/25	S-8	S-8	→
11/12/24	424B3	424B3	→
↓

Filing History(375 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Mar 2, 2026

0000935836-26-000141

—

12.3 KB

8-K

Feb 27, 2026

0001193125-26-0825398-K

Feb 26, 2026

136.6 KB

SCHEDULE 13G

Feb 17, 2026

0001172661-26-001177

—

11.3 KB

8-K

Feb 9, 2026

0001193125-26-0419758-K

Feb 4, 2026

137.6 KB

Feb 6, 2026

0001830059-26-000002

Feb 4, 2026

5.6 KB

Feb 6, 2026

0001874384-26-000002

Feb 4, 2026

5.6 KB

Feb 6, 2026

0001898521-26-000002

Feb 4, 2026

5.6 KB

Feb 6, 2026

0001830914-26-000002

Feb 4, 2026

5.5 KB

424B3

Jan 30, 2026

0001193125-26-031886424B3

—

237.9 KB

SCHEDULE 13G

Jan 29, 2026

0000038777-26-000028

—

29.2 KB

EFFECT

Jan 28, 2026

9999999995-26-000335

—

1.8 KB

S-3

Jan 20, 2026

0001193125-26-016752S-3

—

434.9 KB

SCHEDULE 13D

Jan 2, 2026

0001682638-26-000002

—

28.4 KB

Dec 30, 2025

0001231919-25-000676

—

15.3 KB

SCHEDULE 13G

Dec 30, 2025

0001404574-25-000008

—

11.5 KB

SCHEDULE 13D/A

Dec 29, 2025

0001714576-25-000003

—

48.1 KB

Dec 23, 2025

0001898521-25-000003

Dec 22, 2025

4.9 KB

Dec 23, 2025

0001874384-25-000003

Dec 22, 2025

4.9 KB

Dec 23, 2025

0001830914-25-000003

Dec 22, 2025

8.7 KB

Dec 23, 2025

0001643070-25-000005

Dec 22, 2025

4.9 KB

Dec 23, 2025

0001434099-25-000004

Dec 22, 2025

5.9 KB

Dec 23, 2025

0001682638-25-000004

Dec 22, 2025

7.0 KB

SCHEDULE 13G

Dec 22, 2025

0000935836-25-000732

—

19.0 KB

8-K

Dec 19, 2025

0001193125-25-3270978-K

Dec 18, 2025

726.2 KB

8-K

Nov 24, 2025

0001193125-25-2920578-K

Nov 21, 2025

139.9 KB

25 filings shown

Filed	Form	Description
4/29/25	DEFR14A	DEFR14A	→
3/17/25	DEFA14A	DEFA14A	→
3/17/25	DEF 14A	DEF 14A	→
3/5/25	PRE 14A	PRE 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
↓

IN8BIO, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(375 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/6/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
12/23/25	4	4	→
12/23/25	4	4	→
↓

Filed	Form	Description
3/2/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
1/29/26	SCHEDULE 13G	SCHEDULE 13G	→
1/28/26	EFFECT	EFFECT	→
1/2/26	SCHEDULE 13D	SCHEDULE 13D	→
12/30/25	D	D	→
↓